Patents by Inventor Mark A Pullen

Mark A Pullen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
    Patent number: 6350446
    Abstract: HOEFC11 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HOEFC11 polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, inflammatory diseases, myocardial ischemia, cancer, rheumatoid arthritis, cirrhotic liver disease, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: February 26, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Yuan Zhu, Ponnal Nambi, Mark A Pullen
  • HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
    Patent number: 5994100
    Abstract: HOEFC11 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HOEFC11 polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, inflammatory diseases, myocardial ischemia, cancer, rheumatoid arthritis, cirrhotic liver disease, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: May 29, 1997
    Date of Patent: November 30, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Yuan Zhu, Ponnal Nambi, Mark A Pullen